These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 19355860)
21. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia. Pirillo A; Catapano AL Int J Cardiol; 2013 Dec; 170(2 Suppl 1):S16-20. PubMed ID: 23856442 [TBL] [Abstract][Full Text] [Related]
22. Drugs for hypertriglyceridemia. Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119 [No Abstract] [Full Text] [Related]
23. Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient? Watts GF; Karpe F Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):987-97. PubMed ID: 21878044 [TBL] [Abstract][Full Text] [Related]
24. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Grundy SM Am J Cardiol; 1999 May; 83(9B):25F-29F. PubMed ID: 10357572 [TBL] [Abstract][Full Text] [Related]
25. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia. Gouni-Berthold I Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837 [TBL] [Abstract][Full Text] [Related]
26. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review. Plaisance EP; Grandjean PW; Mahurin AJ Phys Sportsmed; 2009 Apr; 37(1):11-9. PubMed ID: 20048483 [TBL] [Abstract][Full Text] [Related]
27. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
28. Emerging approaches for the treatment of hypertriglyceridemia. Rizzo M; Perez-Martinez P; Nikolic D; Montalto G; Lopez-Miranda J Expert Opin Pharmacother; 2013 Oct; 14(14):1869-73. PubMed ID: 24011268 [TBL] [Abstract][Full Text] [Related]
29. Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates. Kim AM; Somayaji VR; Dong JQ; Rolph TP; Weng Y; Chabot JR; Gropp KE; Talukdar S; Calle RA Diabetes Obes Metab; 2017 Dec; 19(12):1762-1772. PubMed ID: 28573777 [TBL] [Abstract][Full Text] [Related]
30. Combination lipid therapy in type 2 diabetes mellitus. Vergès B Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502 [TBL] [Abstract][Full Text] [Related]
31. Fish oil and the management of hypertriglyceridemia. Mattar M; Obeid O Nutr Health; 2009; 20(1):41-9. PubMed ID: 19326719 [TBL] [Abstract][Full Text] [Related]
32. Hypertriglyceridemia: its etiology, effects and treatment. Yuan G; Al-Shali KZ; Hegele RA CMAJ; 2007 Apr; 176(8):1113-20. PubMed ID: 17420495 [TBL] [Abstract][Full Text] [Related]
33. Fibrates and niacin: is there a place for them in clinical practice? Wierzbicki AS; Viljoen A Expert Opin Pharmacother; 2014 Dec; 15(18):2673-80. PubMed ID: 25318657 [TBL] [Abstract][Full Text] [Related]